This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Provincial Health Services Authority. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Lee Lee Li: Innovator in CXCR4-Targeting Compounds
Introduction
Lee Lee Li is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of medical research, particularly in the development of novel compounds targeting the CXCR4 receptor. His work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Lee Lee Li holds a patent for "Novel CXCR4-Targeting Compounds." This patent represents his innovative approach to addressing medical challenges associated with the CXCR4 receptor. The patent showcases his expertise and commitment to improving healthcare solutions.
Career Highlights
Li is affiliated with the Provincial Health Services Authority, where he applies his knowledge and skills to further research and development in the medical field. His role at this institution allows him to collaborate with other experts and contribute to significant advancements in healthcare.
Collaborations
One of his notable collaborators is Kuo-Shyan Lin. Together, they work on projects that aim to enhance the understanding and treatment of diseases related to the CXCR4 receptor.
Conclusion
Lee Lee Li is a dedicated inventor whose work in CXCR4-targeting compounds is paving the way for innovative medical treatments. His contributions to the field are invaluable and highlight the importance of research in improving health outcomes.